Invention Grant
- Patent Title: Drug formulations
-
Application No.: US16675785Application Date: 2019-11-06
-
Publication No.: US11058705B2Publication Date: 2021-07-13
- Inventor: Rajashree Joshi-Hangal , Chunlin Tang , Sanjeev Redkar , Harish Ravivarapu
- Applicant: Astex Pharmaceuticals, Inc.
- Applicant Address: US CA Pleasanton
- Assignee: Astex Pharmaceuticals, Inc.
- Current Assignee: Astex Pharmaceuticals, Inc.
- Current Assignee Address: US CA Pleasanton
- Agency: Wilson Sonsini Goodrich & Rosati
- Main IPC: A01N43/04
- IPC: A01N43/04 ; A61K31/70 ; A61K31/7084 ; A61K31/706 ; A61K31/7056 ; A61K31/7064 ; A61K31/7052 ; A61K9/00 ; A61K47/10 ; A61K47/20 ; A61K9/19 ; A61K31/708
Abstract:
The invention provides derivatives of decitabine with superior chemical stability and shelf life, with similar physiological activity. The derivatives are provided in a non-aqueous formulation, which further stabilizes the derivatives. Methods of treating one or more myelodysplastic syndromes, leukemia, or solid tumours using the formulations are described.
Public/Granted literature
- US20200155588A1 DRUG FORMULATIONS Public/Granted day:2020-05-21
Information query
IPC分类:
